Delivery Order SPE2DB20D3103-SPE2DB25FP1G1

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,002.44 firm fixed-price delivery order is for the supply of 4,564,462,943 units of Cetirizine HCl 10 mg tablets. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,568.90, is a delivery order for the supply of Cetirizine HCL 10 mg tablets. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,463.26 firm fixed-price delivery order is for the supply of Cetirizine HCL 1 mg/ml solution, 120 ml, to support military healthcare programs. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,083.88 Firm Fixed Price delivery order contract is for the supply of 10 mg Cetirizine HCL tablets. The contract has an ultimate completion date of June 9, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,278.93 for the supply of Cetirizine HCL 1 mg/ml solution. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a performance period that ends on December 28, 2022. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,686.91 firm fixed-price delivery order covers the supply of 4,566,693,120 units of the drug Cetirizine HCL 10 mg tablets. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Cetirizine HCL 10 mg tablets. The contract has a ceiling value of $10,334.41 and is a Firm Fixed Price Delivery Order, with a period of performance through March 19, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Cetirizine HCL 5 mg tablets in quantities of 100 to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price of $2,610.54 and a period of performance through May 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This delivery order contract is not set aside and indicates open competition....
This federal contract award is for the delivery of Cetirizine HCL 5 mg tablets in 100-count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,975.44. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of May 16, 2025. The contract is not set aside for any particular business type....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP1G1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,058.10 firm-fixed-price delivery order for the supply of Cetirizine HCl 5 mg tablets. The award was made by the Defense Logistics Agency (DLA), which is a defense agency. The contract has an ultimate completion date of June 12, 2025 and is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/10/25, 9:56 AM